Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Usage Information

Na+- and Cl–-coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B0,+
Takahiro Hatanaka, Takeo Nakanishi, Wei Huang, Frederick H. Leibach, Puttur D. Prasad, Vadivel Ganapathy, Malliga E. Ganapathy
Takahiro Hatanaka, Takeo Nakanishi, Wei Huang, Frederick H. Leibach, Puttur D. Prasad, Vadivel Ganapathy, Malliga E. Ganapathy
View: Text | PDF
Article

Na+- and Cl–-coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B0,+

  • Text
  • PDF
Abstract

Nitric oxide synthase (NOS) inhibitors have therapeutic potential in the management of numerous conditions in which NO overproduction plays a critical role. Identification of transport systems in the intestine that can mediate the uptake of NOS inhibitors is important to assess the oral bioavailability and therapeutic efficacy of these potential drugs. Here, we have cloned the Na+- and Cl–-coupled amino acid transport system B0,+ (ATB0,+) from the mouse colon and investigated its ability to transport NOS inhibitors. When expressed in mammalian cells, ATB0,+ can transport a variety of zwitterionic and cationic amino acids in a Na+- and Cl–-coupled manner. Each of the NOS inhibitors tested compete with glycine for uptake through this transport system. Furthermore, using a tritiated analog of the NOS inhibitor NG-nitro-L-arginine, we showed that Na+- and Cl–-coupled transport occurs via ATB0,+. We then studied transport of a wide variety of NOS inhibitors in Xenopus laevis oocytes expressing the cloned ATB0,+ and found that ATB0,+ can transport a broad range of zwitterionic or cationic NOS inhibitors. These data represent the first identification of an ion gradient–driven transport system for NOS inhibitors in the intestinal tract.

Authors

Takahiro Hatanaka, Takeo Nakanishi, Wei Huang, Frederick H. Leibach, Puttur D. Prasad, Vadivel Ganapathy, Malliga E. Ganapathy

×

Usage data is cumulative from October 2025 through October 2026.

Usage JCI PMC
Text version 608 37
PDF 212 4
Figure 629 3
Table 200 0
Citation downloads 234 0
Totals 1,883 44
Total Views 1,927
(Click and drag on plot area to zoom in. Click legend items above to toggle)

Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.

Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.

Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts